NEW YORK (GenomeWeb News) – BGI Health and Chile's University of Mayor recently announced an agreement to bring genomic testing to that country and the neighboring region.
Under the terms of the deal, BGI and the university will collaborate on non-invasive fetal trisomy testing, hereditary cancer genomic testing, and monogenic disorder genomic testing. Based in Santiago, Chile, the University of Mayor has a genetic disease diagnosis and treatment center.
"With BGI Health, we will provide patients with early diagnosis and proper treatment, which will greatly improve the life quality of patients and reduce the treatment cost," Alejandro Poli, a professor at the university, said in a statement.
Financial and other details of the agreement were not disclosed.
BGI Health is the clinical arm of BGI. Last month, it forged a deal with Sir Ganga Ram Hospital to bring non-invasive fetal trisomy testing to India, as well as a deal with United Arab Emirates Star Metropolis Clinical Laboratories to introduce genetic testing technologies to the UAE, other Gulf Cooperation Council nations, and the Middle East and African regions.